These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro. Wu Z; Zhang X; Huang Z; Ma K Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328814 [TBL] [Abstract][Full Text] [Related]
4. SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein. Chesney AD; Maiti B; Hansmann UHE J Chem Phys; 2023 Jul; 159(1):. PubMed ID: 37409768 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Idrees D; Kumar V Biochem Biophys Res Commun; 2021 May; 554():94-98. PubMed ID: 33789211 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 N-protein induces the formation of composite α-synuclein/N-protein fibrils that transform into a strain of α-synuclein fibrils. Semerdzhiev SA; Segers-Nolten I; van der Schoot P; Blum C; Claessens MMAE Nanoscale; 2023 Nov; 15(45):18337-18346. PubMed ID: 37921451 [TBL] [Abstract][Full Text] [Related]
7. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein. Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866 [No Abstract] [Full Text] [Related]
8. Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All? Stroylova Y; Konstantinova A; Stroylov V; Katrukha I; Rozov F; Muronetz V Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831034 [TBL] [Abstract][Full Text] [Related]
9. Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils. Jana AK; Lander CW; Chesney AD; Hansmann UHE J Phys Chem B; 2022 May; 126(20):3648-3658. PubMed ID: 35580331 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Spike Protein S1 Domain Accelerates α-Synuclein Phosphorylation and Aggregation in Cellular Models of Synucleinopathy. Wang J; Dai L; Deng M; Xiao T; Zhang Z; Zhang Z Mol Neurobiol; 2024 Apr; 61(4):2446-2458. PubMed ID: 37897633 [TBL] [Abstract][Full Text] [Related]
11. Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently. Mesias VSD; Zhu H; Tang X; Dai X; Liu W; Guo Y; Huang J J Phys Chem Lett; 2022 Nov; 13(45):10642-10648. PubMed ID: 36354180 [TBL] [Abstract][Full Text] [Related]
12. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives. Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Ahmed EA; Batiha GE J Neurosci Res; 2023 Jun; 101(6):952-975. PubMed ID: 36717481 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses. Kumar R; Christensen ND; Kaddis Maldonado RJ; Bewley MC; Ostman A; Sudol M; Chen EC; Buchkovich NW; Gontu A; Surendran Nair M; Nissly RH; Minns AM; Kapur V; Rossi R; Kuchipudi SV; Lindner SE; Parent LJ; Flanagan JM; Buchkovich NJ Viruses; 2021 Sep; 13(10):. PubMed ID: 34696329 [TBL] [Abstract][Full Text] [Related]
14. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
15. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4. Conte C Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186 [TBL] [Abstract][Full Text] [Related]
17. Correlation between Cellular Uptake and Cytotoxicity of Fragmented α-Synuclein Amyloid Fibrils Suggests Intracellular Basis for Toxicity. Zhang X; Wesén E; Kumar R; Bernson D; Gallud A; Paul A; Wittung-Stafshede P; Esbjörner EK ACS Chem Neurosci; 2020 Feb; 11(3):233-241. PubMed ID: 31894960 [TBL] [Abstract][Full Text] [Related]
18. Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an Kesarwani V; Gupta R; Vetukuri RR; Kushwaha SK; Gandhi S Front Immunol; 2021; 12():725240. PubMed ID: 34630400 [TBL] [Abstract][Full Text] [Related]
20. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation. Bai Z; Cao Y; Liu W; Li J Viruses; 2021 Jun; 13(6):. PubMed ID: 34200602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]